JP2012533631A5 - - Google Patents

Download PDF

Info

Publication number
JP2012533631A5
JP2012533631A5 JP2012521703A JP2012521703A JP2012533631A5 JP 2012533631 A5 JP2012533631 A5 JP 2012533631A5 JP 2012521703 A JP2012521703 A JP 2012521703A JP 2012521703 A JP2012521703 A JP 2012521703A JP 2012533631 A5 JP2012533631 A5 JP 2012533631A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
amino acid
acid sequence
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012521703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012533631A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/042423 external-priority patent/WO2011011315A1/en
Publication of JP2012533631A publication Critical patent/JP2012533631A/ja
Publication of JP2012533631A5 publication Critical patent/JP2012533631A5/ja
Pending legal-status Critical Current

Links

JP2012521703A 2009-07-20 2010-07-19 ヒト血清アルブミン(HSA)の変異体と接合したαvβ3インテグリンに対して選択的なポリペプチドおよびその医薬上の使用 Pending JP2012533631A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22694509P 2009-07-20 2009-07-20
US61/226,945 2009-07-20
PCT/US2010/042423 WO2011011315A1 (en) 2009-07-20 2010-07-19 POLYPEPTIDES SELECTIVE FOR AV β3 INTEGRIN CONJUGATED WITH A VARIANT OF HUMAN SERUM ALBUMIN (HSA) AND PHARMACEUTICAL USES THEREOF

Publications (2)

Publication Number Publication Date
JP2012533631A JP2012533631A (ja) 2012-12-27
JP2012533631A5 true JP2012533631A5 (https=) 2013-09-05

Family

ID=43465728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012521703A Pending JP2012533631A (ja) 2009-07-20 2010-07-19 ヒト血清アルブミン(HSA)の変異体と接合したαvβ3インテグリンに対して選択的なポリペプチドおよびその医薬上の使用

Country Status (14)

Country Link
US (1) US20110015130A1 (https=)
EP (1) EP2456454A4 (https=)
JP (1) JP2012533631A (https=)
KR (1) KR20120097481A (https=)
CN (1) CN102470156A (https=)
AR (1) AR077764A1 (https=)
AU (1) AU2010276453A1 (https=)
CA (1) CA2768360A1 (https=)
IL (1) IL217424A0 (https=)
MX (1) MX2012000895A (https=)
NZ (1) NZ597580A (https=)
RU (1) RU2547592C2 (https=)
TW (1) TWI557224B (https=)
WO (1) WO2011011315A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101722961B1 (ko) 2009-02-11 2017-04-04 알부메딕스 에이/에스 알부민 변이체 및 접합체
EP2493921B1 (en) 2009-10-30 2018-09-26 Albumedix Ltd Albumin variants
US8357652B2 (en) * 2009-11-20 2013-01-22 Academia Sinica Anti-tumor fibrillar human serum albumin methods and compositions
NZ600544A (en) * 2009-12-23 2014-06-27 Univ Nat Cheng Kung Compositions and methods for the treatment of angiogenesis-related eye diseases
KR20130020765A (ko) 2010-02-16 2013-02-28 메디뮨 엘엘씨 Hsa-관련 조성물 및 사용방법
EP2556087A1 (en) 2010-04-09 2013-02-13 Novozymes Biopharma DK A/S Albumin derivatives and variants
US9045564B2 (en) 2011-02-15 2015-06-02 Medimmune, Llc HSA-related compositions and methods of use
CA2830660A1 (en) 2011-05-05 2012-11-08 Novozymes Biopharma Dk A/S Albumin variants
EP2780364A2 (en) 2011-11-18 2014-09-24 Eleven Biotherapeutics, Inc. Proteins with improved half-life and other properties
DK2825556T3 (en) 2012-03-16 2018-04-16 Albumedix As albumin Variants
MX2015005363A (es) 2012-11-08 2015-11-06 Novozymes Biopharma Dk As Variantes de albumina.
JP6886917B2 (ja) * 2014-08-22 2021-06-16 國立成功大學National Cheng Kung University ロドストミンバリアント、ロドストミンバリアントをコードするポリヌクレオチド、当該ポリヌクレオチドを含む組換え宿主細胞、及びロドストミンバリアントを含む医薬組成物
WO2017001990A1 (en) * 2015-06-28 2017-01-05 Allgenesis Biotherapeutics Inc. Fusion proteins for inhibiting angiogenesis
AU2016304794B2 (en) 2015-08-07 2021-07-15 ALX Oncology Inc. Constructs having a SIRP-alpha domain or variant thereof
EA034582B1 (ru) * 2015-08-07 2020-02-21 АЭлЭкс ОНКОЛОДЖИ ИНК. Конструкции варианта sirp-альфа и их применение
JP7007261B2 (ja) 2015-08-20 2022-01-24 アルブミディクス リミティド アルブミン変異体及びコンジュゲート
US10336812B2 (en) * 2016-05-10 2019-07-02 Janssen Biotech, Inc. GDF15 fusion proteins and uses thereof
EA202191105A1 (ru) 2018-10-22 2021-08-03 Янссен Фармацевтика Нв Слитые белки, полученные из глюкагоноподобного пептида 1 (glp1) и ростового фактора дифференцировки 15 (gdf15), и их применение
CN114126648A (zh) 2019-05-31 2022-03-01 Alx肿瘤生物技术公司 用SIRPα Fc融合体组合免疫检查点抑制剂治疗癌症的方法
CN121243368A (zh) 2019-11-27 2026-01-02 Alx肿瘤生物技术公司 用于治疗癌症的组合疗法
US20240148839A1 (en) * 2021-03-16 2024-05-09 Km Biologics Co., Ltd. Modified human serum albumin-thioredoxin fusion body
JP2024520902A (ja) 2021-05-13 2024-05-27 エーエルエックス オンコロジー インコーポレイテッド がんを治療するための併用療法
WO2026022392A1 (en) * 2024-07-26 2026-01-29 Ospedale San Raffaele S.R.L. Peptide and conjugates thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) * 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) * 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
EP0206448B1 (en) * 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4791192A (en) * 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
AU5939890A (en) * 1989-06-07 1991-01-07 Genentech Inc. Platelet aggregation inhibitors and related molecules
US5525708A (en) * 1994-03-28 1996-06-11 Cytomed, Inc. Covalent dimer of kit ligand
WO2003042354A2 (en) * 2001-09-04 2003-05-22 Aventis Pharmaceuticals Inc. Abrogen polypeptides, nucleic acids encoding them and methods for using them to inhibit angiogenesis
WO2003040384A1 (en) * 2001-11-05 2003-05-15 Board Of Regents, The University Of Texas System Recombinant antibodies for the detection and neutralization of anthrax toxin
KR101271635B1 (ko) * 2001-12-21 2013-06-12 휴먼 게놈 사이언시즈, 인코포레이티드 알부민 융합 단백질
JP2005529166A (ja) * 2002-06-07 2005-09-29 ウィスコンシン アルムニ リサーチ ファウンデーション ペプチドカップリングのための試薬の化学合成
EP1730187A1 (en) * 2004-03-18 2006-12-13 The University Court Of The University Of Glasgow Immunosuppressive cytokine
WO2008056961A1 (en) * 2006-11-10 2008-05-15 Boryung Pharmaceutical Co., Ltd A novel fusion protein, cell lines expressing the same and preparation method thereof
US7943728B2 (en) * 2006-12-26 2011-05-17 National Cheng Kung University Disintegrin variants and their use in treating osteoporosis-induced bone loss and angiogenesis-related diseases
US8183201B2 (en) * 2006-12-26 2012-05-22 National Cheng Kung University Methods of treating αvβ3 integrin-associated diseases by administering polypeptides selective for αvβ3 integrin
NZ600544A (en) * 2009-12-23 2014-06-27 Univ Nat Cheng Kung Compositions and methods for the treatment of angiogenesis-related eye diseases

Similar Documents

Publication Publication Date Title
JP2012533631A5 (https=)
RU2012105915A (ru) ПОЛИПЕПТИДЫ, СЕЛЕКТИВНЫЕ В ОТНОШЕНИИ ИНТЕГРИНА ανβ, КОНЪЮГИРОВАННЫЕ С ВАРИАНТОМ ЧЕЛОВЕЧЕСКОГО СЫВОРОТОЧНОГО АЛЬБУМИНА (HSA), И ИХ ФАРМАЦЕВТИЧЕСКИЕ ПРИМЕНЕНИЯ
ES2361621T7 (es) Peptidos de lactoferrina utiles como peptidos de penetracion celular.
WO2012142320A8 (en) Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
US9133272B2 (en) Bispecific binding agents
JP6948250B2 (ja) Larファミリーホスファターゼの活性を阻害する組成物及び方法
JP2020040969A5 (https=)
CN102883738A (zh) 治疗血管发生相关的眼部疾病的组合物和方法
JP2012176978A5 (https=)
TW201521741A (zh) 治療或預防眼科疾病的方法
JP2017529059A5 (https=)
TW201427994A (zh) 用於血腦屏障運輸之多肽
KR20090090331A (ko) 혈관 신생 억제 화합물
JP2010502371A5 (https=)
JP2017537896A5 (https=)
KR20200078425A (ko) 재조합 변형된 섬유아세포 성장 인자 및 이의 치료적 용도
KR102156324B1 (ko) 핵산 복합체를 유효성분으로 함유하는 혈관신생관련 질환 치료용 약학 조성물
HK1216007A1 (zh) 人体生长激素和白蛋白的融合、制剂及其用途
JP5752782B2 (ja) 血管新生促進用ペプチド及びその使用
JP2017524727A5 (https=)
JP2014526890A5 (https=)
JP7239987B2 (ja) 薬物送達のための抗体融合タンパク質
US9469679B2 (en) Neurturin molecules
JP2012507278A (ja) 短縮型ヒトrnaset2の大腸菌における効率的発現
JP2023509067A (ja) コドン最適化TIF1γポリヌクレオチドを含む組換えベクターおよびその用途